Cargando…

Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis

CONTEXT: Styrax is used for prevention and treatment of cerebrovascular diseases. However, the underlying mechanism remains unclear. OBJECTIVE: To elucidate styrax’s anti-ischemic stroke protective effects and underlying mechanisms. MATERIALS AND METHODS: An ischemic-stroke rat model was established...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Fei, Lin, Rui, Lu, Xueyan, Zhao, Meina, Zhao, Jiaxin, Huang, Shaojie, Guo, Chao, Guan, Yue, Zhang, Haiyue, Xi, Miaomiao, Wang, Jingwen, Tang, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461497/
https://www.ncbi.nlm.nih.gov/pubmed/37621078
http://dx.doi.org/10.1080/13880209.2023.2246501
_version_ 1785097851613741056
author Mu, Fei
Lin, Rui
Lu, Xueyan
Zhao, Meina
Zhao, Jiaxin
Huang, Shaojie
Guo, Chao
Guan, Yue
Zhang, Haiyue
Xi, Miaomiao
Wang, Jingwen
Tang, Haifeng
author_facet Mu, Fei
Lin, Rui
Lu, Xueyan
Zhao, Meina
Zhao, Jiaxin
Huang, Shaojie
Guo, Chao
Guan, Yue
Zhang, Haiyue
Xi, Miaomiao
Wang, Jingwen
Tang, Haifeng
author_sort Mu, Fei
collection PubMed
description CONTEXT: Styrax is used for prevention and treatment of cerebrovascular diseases. However, the underlying mechanism remains unclear. OBJECTIVE: To elucidate styrax’s anti-ischemic stroke protective effects and underlying mechanisms. MATERIALS AND METHODS: An ischemic-stroke rat model was established based on middle cerebral artery occlusion (MCAO). Sprague-Dawley rats were randomly assigned to the following groups (n = 10) and administered intragastrically once a day for 7 consecutive days: sham, model, nimodipine (24 mg/kg), styrax-L (0.1 g/kg), styrax-M (0.2 g/kg) and styrax-H (0.4 g/kg). Neurological function, biochemical assessment, and ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS)-based serum metabonomics were used to elucidate styrax’s cerebral protective effects and mechanisms. Pearson correlation and western blot analyses were performed to verify. RESULTS: The addition of 0.4 g/kg styrax significantly reduced cerebral infarct volume and neurobehavioral abnormality score. Different doses of styrax also decrease MDA, TNF-α, IL-6, and IL-1β, and increase SOD and GSH-Px in ischemic-stroke rats (p < 0.05; MDA, p < 0.05 only at 0.4 g/kg dose). Biochemical indicators and metabolic-profile analyses (PCA, PLS-DA, and OPLS-DA) also supported styrax’s protective effects. Endogenous metabolites (22) were identified in ischemic-stroke rats, and these perturbations were reversible via styrax intervention, which is predominantly involved in energy metabolism, glutathione and glutamine metabolism, and other metabolic processes. Additionally, styrax significantly upregulated phosphorylated AMP-activated protein kinase and glutaminase brain-tissue expression. CONCLUSION: Styrax treatment could ameliorate ischemic-stroke rats by intervening with energy metabolism and glutamine metabolism. This can help us understand the mechanism of styrax, inspiring more clinical application and promotion.
format Online
Article
Text
id pubmed-10461497
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-104614972023-08-29 Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis Mu, Fei Lin, Rui Lu, Xueyan Zhao, Meina Zhao, Jiaxin Huang, Shaojie Guo, Chao Guan, Yue Zhang, Haiyue Xi, Miaomiao Wang, Jingwen Tang, Haifeng Pharm Biol Research Article CONTEXT: Styrax is used for prevention and treatment of cerebrovascular diseases. However, the underlying mechanism remains unclear. OBJECTIVE: To elucidate styrax’s anti-ischemic stroke protective effects and underlying mechanisms. MATERIALS AND METHODS: An ischemic-stroke rat model was established based on middle cerebral artery occlusion (MCAO). Sprague-Dawley rats were randomly assigned to the following groups (n = 10) and administered intragastrically once a day for 7 consecutive days: sham, model, nimodipine (24 mg/kg), styrax-L (0.1 g/kg), styrax-M (0.2 g/kg) and styrax-H (0.4 g/kg). Neurological function, biochemical assessment, and ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS)-based serum metabonomics were used to elucidate styrax’s cerebral protective effects and mechanisms. Pearson correlation and western blot analyses were performed to verify. RESULTS: The addition of 0.4 g/kg styrax significantly reduced cerebral infarct volume and neurobehavioral abnormality score. Different doses of styrax also decrease MDA, TNF-α, IL-6, and IL-1β, and increase SOD and GSH-Px in ischemic-stroke rats (p < 0.05; MDA, p < 0.05 only at 0.4 g/kg dose). Biochemical indicators and metabolic-profile analyses (PCA, PLS-DA, and OPLS-DA) also supported styrax’s protective effects. Endogenous metabolites (22) were identified in ischemic-stroke rats, and these perturbations were reversible via styrax intervention, which is predominantly involved in energy metabolism, glutathione and glutamine metabolism, and other metabolic processes. Additionally, styrax significantly upregulated phosphorylated AMP-activated protein kinase and glutaminase brain-tissue expression. CONCLUSION: Styrax treatment could ameliorate ischemic-stroke rats by intervening with energy metabolism and glutamine metabolism. This can help us understand the mechanism of styrax, inspiring more clinical application and promotion. Taylor & Francis 2023-08-24 /pmc/articles/PMC10461497/ /pubmed/37621078 http://dx.doi.org/10.1080/13880209.2023.2246501 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Research Article
Mu, Fei
Lin, Rui
Lu, Xueyan
Zhao, Meina
Zhao, Jiaxin
Huang, Shaojie
Guo, Chao
Guan, Yue
Zhang, Haiyue
Xi, Miaomiao
Wang, Jingwen
Tang, Haifeng
Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
title Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
title_full Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
title_fullStr Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
title_full_unstemmed Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
title_short Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
title_sort protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by uplc-q/tof-ms analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461497/
https://www.ncbi.nlm.nih.gov/pubmed/37621078
http://dx.doi.org/10.1080/13880209.2023.2246501
work_keys_str_mv AT mufei protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT linrui protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT luxueyan protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT zhaomeina protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT zhaojiaxin protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT huangshaojie protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT guochao protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT guanyue protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT zhanghaiyue protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT ximiaomiao protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT wangjingwen protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis
AT tanghaifeng protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis